Off-label Prescriptions: how to Identify Them, Frame Them, Announce Them and Monitor Them in Practice?
Therapie, 68 4 (2013) 233-239
Published online: 2013-08-28
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Off-label treatment of atopic dermatitis and psoriasis
Julia Sternicka-Rohde, Leszek Bieniaszewski, Roman J. Nowicki and Dorota Purzycka-BohdanJournal of Dermatological Treatment 37 (1) (2026)
https://doi.org/10.1080/09546634.2026.2617768
La prescripción off label
Estela Azaustre Lago, Cristina Armenteros Gil and Susana Aldecoa LandesaActualización en Medicina de Familia 3721 (2024)
https://doi.org/10.55783/AMF.S201106
Appropriateness of Prescribing Transmucosal Immediate-Release Fentanyl in the Emergency Room, During Hospitalization, and at Discharge: A Retrospective Study
Gary Punjabi and Elena RamírezPharmaceuticals 17 (12) 1609 (2024)
https://doi.org/10.3390/ph17121609
Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022
Valentina Petkova, Dilyana Georgieva, Milen Dimitrov and Irina NikolovaPharmaceutics 15 (12) 2652 (2023)
https://doi.org/10.3390/pharmaceutics15122652
Sales of “COVID kit” drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency
Marina Hentschke-Lopes, Mariana R. Botton, Pâmella Borges, Martiela Freitas, Aline Castello Branco Mancuso and Ursula MatteCadernos de Saúde Pública 38 (7) (2022)
https://doi.org/10.1590/0102-311xen001022
Management guideline for the off-label use of medicine in China (2021)
Wei Zuo, Yajia Sun, Rongji Liu, Liping Du, Nan Yang, Wenjuan Sun, Ping Wang, Xiaowan Tang, Yunlan Liu, Yuanyuan Ma, Min Meng, Ruobing Lei, Xuelian Yan, Hua Peng, Qing Chang, Hui Pan, Bo Zhang, Yaolong Chen and Shuyang ZhangExpert Review of Clinical Pharmacology (2022)
https://doi.org/10.1080/17512433.2022.2120468
How often are antidepressants prescribed off‐label among older adults in Germany? A claims data analysis
Wiebke Schäfer, Tammo Reinders, Oliver Riedel and Ulrike HaugBritish Journal of Clinical Pharmacology (2020)
https://doi.org/10.1111/bcp.14564
Coronavirus Disease 2019 Treatment: It is Time for Stewardship!
Indian Journal of Critical Care Medicine 24 (10) 895 (2020)https://doi.org/10.5005/jp-journals-10071-23622
Use of non-formulary high-cost medicines in an Australian public hospital
Joshua M. Inglis, Gillian E. Caughey and Sepehr ShakibInternational Journal of Clinical Pharmacy 41 (4) 920 (2019)
https://doi.org/10.1007/s11096-019-00853-z
https://doi.org/10.1002/9781118912065.bref
The “Temporary Recommendations for Use”: A dual-purpose regulatory framework for off-label drug use in France
Albane Degrassat-Théas, François Bocquet, Martine Sinègre, Jérôme Peigné and Pascal PaubelHealth Policy 119 (11) 1399 (2015)
https://doi.org/10.1016/j.healthpol.2015.09.003